PRESENTATION TITLE

Treatment of Patients with Metastatic BRAF Mutant Melanoma:  To Sequence or Combine


PRESENTER(S)
Michael B. Atkins, M.D., Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center | Scholl Professor and Vice Chair Department of Oncology, Georgetown University Medical Center, Washington, DC

PRESENTER BIO

Dr. Atkins began his career at Tufts before moving to Beth Israel Deaconess Medical Center and being appointed Professor at Harvard Medical School where he served as Deputy Chief of the Division of Hematology/Oncology and leader of the Biologic Therapy and Cutaneous Oncology Programs, Co-PI of the Harvard Skin Cancer SPORE, founding leader of the DF/HCC Kidney Cancer Program and Director of the DF/HCC Kidney Cancer SPORE.  In 2012, he moved to Georgetown where he is Deputy Director of the Georgetown Lombardi Comprehensive Cancer Center and William Scholl Professor and Vice Chair of the Department of Oncology. He leads the Lombardi Immunotherapy Initiative.  His current research focuses on immunotherapy for melanoma and RCC and biomarkers for response and toxicity. He has published over 450 articles and 5 books and has lectured extensively on these topics.  He is past president of SITC and co-Chairs the Melanoma Research Foundation Scientific Advisory Council.

VIEWING LOCATIONS
Zoom Registration Link

LEARNING OBJECTIVES

• Choose the optimal initial treatment and sequence of treatments for patients with metastatic BRAF mutant melanoma.
• Describe the different effects of targeted therapy and immunotherapy on early and late outcomes in patients with metastatic BRAF mutant melanoma.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.